Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc. is a development-stage biotechnology company based in the United States, focused on developing proprietary therapeutics using its clinically proven ProNeura® long-term, continuous drug delivery technology. The company's pipeline includes a kappa opioid receptor agonist implant for the treatment of chronic pruritus and a nalmefene implant for the prevention of relapse in opioid use disorder patients.